311
Views
2
CrossRef citations to date
0
Altmetric
Original Articles

Can treatment response to SGLT2-inhibitors in syndrome of inappropriate antidiuresis be predicted by copeptin, natriuretic peptides and inflammatory markers?

ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon
Pages 647-655 | Received 27 Apr 2021, Accepted 15 Aug 2021, Published online: 30 Aug 2021

References

  • Bartter, F.C. and Schwartz, W.B., 1967. The syndrome of inappropriate secretion of antidiuretic hormone. The American journal of medicine, 42 (5), 790–806.
  • Berni, A., et al., 2020. Hyponatremia, IL-6, and SARS-CoV-2 (COVID-19) infection: may all fit together? Journal of endocrinological investigation, 43 (8), 1137–1139.
  • Black, S., Kushner, I., and Samols, D., 2004. C-reactive Protein. The journal of biological chemistry, 279 (47), 48487–48490.
  • Christ-Crain, M., 2019. Vasopressin and Copeptin in health and disease. Reviews in endocrine & metabolic disorders, 20 (3), 283–294.
  • Cogan, E., et al., 1988. Natriuresis and atrial natriuretic factor secretion during inappropriate antidiuresis. The American journal of medicine, 84 (3), 409–418.
  • Cuesta, M. and Thompson, C.J., 2016. The syndrome of inappropriate antidiuresis (SIAD). Best practice & research. Clinical endocrinology & metabolism, 30 (2), 175–187.
  • Eggers, K.M., Venge, P., and Lind, L., 2013. Mid-regional pro-atrial natriuretic peptide levels in the elderly: clinical and prognostic implications, and comparison to B-type natriuretic peptides. Clinica chimica acta; international journal of clinical chemistry, 419, 62–66.
  • Fenske, W.K., et al., 2018. Release and decay kinetics of copeptin vs. AVP in response to osmotic alterations in healthy volunteers. The journal of clinical endocrinology and metabolism, 103 (2), 505–513.
  • Fenske, W., Sandner, B., and Christ-Crain, M., 2016. A copeptin-based classification of the osmoregulatory defects in the syndrome of inappropriate antidiuresis. Best practice & research. Clinical endocrinology & metabolism, 30 (2), 219–233.
  • Hannon, M.J., et al., 2014. Hyponatremia following mild/moderate subarachnoid hemorrhage is due to SIAD and glucocorticoid deficiency and not cerebral salt wasting. The journal of clinical endocrinology & metabolism, 99 (1), 291–298.
  • Hannon, M.J. and Thompson, C.J., 2010. The syndrome of inappropriate antidiuretic hormone: prevalence, causes and consequences. European journal of endocrinology, 162 (1), S5–S12.
  • Holland-Bill, L., et al., 2015. Hyponatremia and mortality risk: a Danish cohort study of 279 508 acutely hospitalized patients. European journal of endocrinology, 173 (1), 71–81.
  • Holm, E.A., et al., 2009. Diagnosis of the syndrome of inappropriate secretion of antidiuretic hormone. Southern medical journal, 102 (4), 380–384.
  • Januzzi, J.L., et al., 2006. NT-proBNP testing for diagnosis and short-term prognosis in acute destabilized heart failure: an international pooled analysis of 1256 patients: the International Collaborative of NT-proBNP Study. European heart journal, 27 (3), 330–337.
  • Kamoi, K., et al., 1990. Atrial natriuretic peptide in patients with the syndrome of inappropriate antidiuretic hormone secretion and with diabetes insipidus. The journal of clinical endocrinology and metabolism, 70 (5), 1385–1390.
  • Lockett, J., et al., 2019. Urea treatment in fluid restriction-refractory hyponatraemia. Clinical endocrinology, 90 (4), 630–636.
  • Manoogian, C., et al., 1988. Plasma atrial natriuretic hormone levels in patients with the syndrome of inappropriate antidiuretic hormone secretion. The journal of clinical endocrinology and metabolism, 67 (3), 571–575.
  • Mastorakos, G., et al., 1994. Hypothalamic-pituitary-adrenal axis activation and stimulation of systemic vasopressin secretion by recombinant interleukin-6 in humans: potential implications for the syndrome of inappropriate vasopressin secretion. The journal of clinical endocrinology and metabolism, 79 (4), 934–939.
  • Morgenthaler, N.G., et al., 2004. Immunoluminometric assay for the midregion of pro-atrial natriuretic peptide in human plasma. Clinical chemistry, 50 (1), 234–236.
  • Nakagawa, Y., Nishikimi, T., and Kuwahara, K., 2019. Atrial and brain natriuretic peptides: Hormones secreted from the heart. Peptides, 111, 18–25.
  • Nigro, N., et al., 2015. Mid-regional pro-atrial natriuretic peptide and the assessment of volaemic status and differential diagnosis of profound hyponatraemia. Journal of internal medicine, 278 (1), 29–37.
  • Potocki, M., et al., 2010. Comparison of midregional pro-atrial natriuretic peptide with N-terminal pro-B-type natriuretic peptide in the diagnosis of heart failure. Journal of internal medicine, 267 (1), 119–129.
  • R Core Team. 2020. R: a language and environment for statistical computing. Vienna, Austria: R Foundation for Statistical Computing.
  • Refardt, J., et al., 2017. Artificial syndrome of inappropriate antidiuresis model as potential use for diagnostic and therapeutic strategies. Hormone and metabolic research hormon- und stoffwechselforschung hormones et metabolisme, 49 (9), 673–679.
  • Refardt, J., et al., 2020. A randomized trial of empagliflozin to increase plasma sodium levels in patients with the syndrome of inappropriate antidiuresis. Journal of the American society of nephrology, 31 (3), 615–624.
  • Renneboog, B., et al., 2006. Mild chronic hyponatremia is associated with falls, unsteadiness, and attention deficits. The American journal of medicine, 119 (1), 71.e1-8.
  • Swart, R.M., et al., 2011. Hyponatremia and inflammation: the emerging role of interleukin-6 in osmoregulation. Nephron physiology, 118 (2), 45–51.
  • Usala, R.L., et al., 2015. Hyponatremia is associated with increased osteoporosis and bone fractures in a large US health system population. The journal of clinical endocrinology and metabolism, 100 (8), 3021–3031.
  • Verbalis, J.G., et al., 2013. Diagnosis, evaluation, and treatment of hyponatremia: expert panel recommendations. The American journal of medicine, 126 (10), S1–S42.
  • Verbalis, J.G., et al., 2016. Diagnosing and treating the syndrome of inappropriate antidiuretic hormone secretion. The American journal of medicine, 129 (5), 537.e9–537.e23.
  • Wald, R., et al., 2010. Impact of hospital-associated hyponatremia on selected outcomes. Archives of internal medicine, 170 (3), 294–302.
  • Winzeler, B., et al., 2016a. Long-term outcome of profound hyponatremia: a prospective 12 months follow-up study. European journal of endocrinology of the European federation of endocrine societies, 175, 499–507.
  • Winzeler, B., et al., 2016b. Predictors of nonresponse to fluid restriction in hyponatraemia due to the syndrome of inappropriate antidiuresis. Journal of internal medicine, 280 (6), 609–617.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.